BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 26436510)

  • 21. Ebp1 p48 promotes oncogenic activities in human colon cancer cells through regulation of TIF-90-mediated ribosomal RNA synthesis.
    Nguyen DQ; Hoang DH; Nguyen TTV; Ho HD; Huynh V; Shin JH; Ly QT; Thi Nguyen DD; Ghoda L; Marcucci G; Nguyen LXT
    J Cell Physiol; 2019 Aug; 234(10):17612-17621. PubMed ID: 30793766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Opposing roles of the two isoforms of ErbB3 binding protein 1 in human cancer cells.
    Ko HR; Chang YS; Park WS; Ahn JY
    Int J Cancer; 2016 Sep; 139(6):1202-8. PubMed ID: 27130196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel Anxa2-interacting protein Ebp1 inhibits cancer proliferation and invasion by suppressing Anxa2 protein level.
    Zhang F; Liu Y; Wang Z; Sun X; Yuan J; Wang T; Tian R; Ji W; Yu M; Zhao Y; Niu R
    Mol Cell Endocrinol; 2015 Aug; 411():75-85. PubMed ID: 25917452
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Overexpression of p53 is associated with growth pattern and prognosis in advanced gastric cancer.
    Ichiyoshi Y; Oiwa H; Tomisaki S; Sakaguchi Y; Ohno S; Maehara Y; Sugimachi K
    Hepatogastroenterology; 1997; 44(14):546-53. PubMed ID: 9164535
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Worse Prognosis in Cervical Cancers.
    Cho U; Kim HM; Park HS; Kwon OJ; Lee A; Jeong SW
    PLoS One; 2016; 11(9):e0162623. PubMed ID: 27611086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer.
    Zhang Y; Ali TZ; Zhou H; D'Souza DR; Lu Y; Jaffe J; Liu Z; Passaniti A; Hamburger AW
    Cancer Res; 2010 Jan; 70(1):240-8. PubMed ID: 20048076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression and Role of the ErbB3-Binding Protein 1 in Acute Myelogenous Leukemic Cells.
    Nguyen le XT; Zhu L; Lee Y; Ta L; Mitchell BS
    Clin Cancer Res; 2016 Jul; 22(13):3320-7. PubMed ID: 26813358
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of immunohistochemically detected p53 protein expression in stage IIIB squamous cell carcinoma of the uterine cervix treated with radiation therapy alone.
    Ebara T; Mitsuhashi N; Saito Y; Sakurai H; Hasegawa M; Takahashi M; Takahashi T; Hayakawa K; Niibe H
    Gynecol Oncol; 1996 Nov; 63(2):216-8. PubMed ID: 8910630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions.
    Dimitrakakis C; Kymionis G; Diakomanolis E; Papaspyrou I; Rodolakis A; Arzimanoglou I; Leandros E; Michalas S
    Gynecol Oncol; 2000 Apr; 77(1):129-36. PubMed ID: 10739702
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of p53, Ki-67, and CD31 in the vaginal margins of radical hysterectomy in patients with stage IB carcinoma of the cervix.
    Silva-Filho AL; Traiman P; Triginelli SA; Reis FM; Pedrosa MS; Miranda D; Abreu ES; Macarenco RS; Cunha-Melo JR
    Gynecol Oncol; 2004 Dec; 95(3):646-54. PubMed ID: 15581977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A single-codon mutation converts HPV16 E6 oncoprotein into a potential tumor suppressor, which induces p53-dependent senescence of HPV-positive HeLa cervical cancer cells.
    Ristriani T; Fournane S; Orfanoudakis G; Travé G; Masson M
    Oncogene; 2009 Feb; 28(5):762-72. PubMed ID: 19015633
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased expression of lncRNA GAS5 predicts a poor prognosis in cervical cancer.
    Cao S; Liu W; Li F; Zhao W; Qin C
    Int J Clin Exp Pathol; 2014; 7(10):6776-83. PubMed ID: 25400758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between Aurora-A expression and the prognosis of cervical carcinoma patients.
    Zhang W; Wang J; Liu SJ; Hua W; Xin XY
    Acta Obstet Gynecol Scand; 2009; 88(5):521-7. PubMed ID: 19306133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clusterin expression predicts survival of invasive cervical cancer patients treated with radical hysterectomy and systematic lymphadenectomy.
    Watari H; Ohta Y; Hassan MK; Xiong Y; Tanaka S; Sakuragi N
    Gynecol Oncol; 2008 Mar; 108(3):527-32. PubMed ID: 18177691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Expression and clinical significance of p53 and c-erbB2 in geriatric women with cervical carcinoma].
    Huang YW; Li MD; Wu QL; Liu FY
    Ai Zheng; 2002 Mar; 21(3):297-300. PubMed ID: 12451999
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ebp1 activates podoplanin expression and contributes to oral tumorigenesis.
    Mei Y; Zhang P; Zuo H; Clark D; Xia R; Li J; Liu Z; Mao L
    Oncogene; 2014 Jul; 33(29):3839-50. PubMed ID: 23975429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p53 and p21 expression in precancerous lesions and carcinomas of the uterine cervix: overexpression of p53 predicts poor disease outcome.
    Huang LW; Chou YY; Chao SL; Chen TJ; Lee TT
    Gynecol Oncol; 2001 Nov; 83(2):348-54. PubMed ID: 11606096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
    Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
    Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.